News | February 18, 2023
Asahi Kasei completes construction of microcrystalline cellulose plant
With the new facility, the company underlines its commitment to meet the substantially growing demand for its MCC
With the new facility, the company underlines its commitment to meet the substantially growing demand for its MCC
Qure.ai is scaling-up the integration of its AI-powered chest x-ray interpretation tool that can benefit early and easy detection of lung diseases including lung cancer.
It dwells on colocating 157 nursing colleges with medical colleges and eliminating sickle cell anaemia by 2047
Diagnostic imaging will become an increasingly vital process in healthcare
The only robotic-arm assisted surgical device to conduct joint replacement with accuracy and better clinical outcomes
Cell sorting technology supports researchers advancing new therapies
Products offered on a not-for-profit basis to the 45 lower-income countries now include the full portfolio for which Pfizer has global rights.
Through the new agreements, Cristal Therapeutics and McSAF will gain access to Lonza’s integrated bioconjugates offering and will be able to leverage Lonza’s expertise in developing and manufacturing bioconjugates
He urged the dignitaries to collaboratively work on the identified domains of improvement and make detailed reports on them
Subscribe To Our Newsletter & Stay Updated
